A New Association to Promote Algae
SWALG – the Swiss Algae Consortium Association – was founded in May 2018. It is a non-profit organization that serves as a platform to promote algae-related...
More details More detailsA Digital Copy of the World
Nomoko AG is developing the platform that will contribute to the creation of an entirely new market for products built on real-world-based 3D data. The core of the platform is built on Nomoko’s technology that will enable them to create accurate, ultra-realistic 3D models of the cities we live in – also called the “digital twin of the world”.
More detailsSwitzerland's Strenghts Gain International Attention
Switzerland as a hotspot for machine learning, the Swiss higher education system as the second best in the world and a quite positive article about Switzerland...
More detailsStimulating the Human Body's Self-Healing Powers
Given the constantly aging global population, the importance of regenerative treatment methods is increasing all the time. At Switzerland Innovation Park...
More detailsWe Have Conquered the Valley of Death
joysteer, the electronic driving system for people with physical disabilities, was originally a spin-off company of Bern University of Applied Sciences...
More detailsRobotics: Innovation and R&D in Switzerland
Forbes recently called Switzerland “the Silicon Valley of Robotics” and said the country has “emerged as a serious competitor to California for the technologies, people and funding that will power the world’s fourth socio-economic revolution”. Find out why.
More detailsDrug Discovery Made in Switzerland
Drug discovery has come a long way from guess work to a structural and targeted approach to finding new and better remedies. To develop new drugs, companies need to stay up to date about the latest discoveries in genomics, proteomics, structural or quantitative biology.
More detailsStimulating the Human Body's Self-Healing Powers
Given the constantly aging global population, the importance of regenerative treatment methods is increasing all the time. At Switzerland Innovation Park...
More detailsStructure-based Drug Discovery Drives the Development of Novel Treatment Options
Drug development is a long and unpredictable process that requires high levels of investment, endurance and state-of-the-art technology. Basic research...
More detailsIt’s Now a Case of Knuckling Down until We’re Airborne!
One of the first tenants at Switzerland Innovation Park Biel/Bienne, start-up company evolaris aviation is working with the Swiss aircraft manufacturer...
More detailsInterview with Dr. René Cotting, ABB Group
Knowledge and innovation are the key to the success of Switzerland – and ABB. But we can only remain successful if we continue to invest in top talents...
More detailsShaping the future of modern drug discovery
Pharmaceutical and biotechnological industries often depend on the information acquired through basic research. To develop new drugs, for instance, companies...
More details